A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008 Meeting Abstract
| Authors: | Braunstein, L. Z.; Mitchell, M.; Bandos, H.; Sikov, W. M.; Khan, A. J.; Chen, P. Y.; Ganz, P. A.; Jagsi, R.; White, J. R.; Cecchini, R. S.; Kang, H.; Puhalla, S. L.; Bolton, K. L.; Connolly, E.; Stringer-Reasor, E. M.; Gergelis, K.; Julian, T. B.; Mamounas, E. P.; Wolmark, N. |
| Abstract Title: | A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008 |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | TPS1120 |
| Language: | English |
| ACCESSION: | WOS:001509472400001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.TPS1120 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
